News | Ultrasound Imaging | July 27, 2023

The initiative aims to help high-potential Canadian firms with over $30m in revenues to scale and become anchor firms for Canada 

The initiative aims to help high-potential Canadian firms with over $30m in revenues to scale and become anchor firms for Canada

The Clarius team has an ambitious mission to improve patient care globally and reduce healthcare costs by enabling clinicians to instantly look into a patient’s body to confidently diagnose disease and enhance procedural safety. The company was the first to develop a high-definition pocket-size wireless ultrasound scanner that works with an app on Apple and Android smart devices. (Photo: Business Wire) 


July 27, 2023 — Clarius Mobile Health, a leading provider of high-definition handheld ultrasound systems, has been selected by the Government of Canada to participate in the new Global Hypergrowth Project (GHP), powered by the Federal Ministry of Innovation, Science, and Economic Development. GHP is designed to help the country’s most promising scale-up companies to further fuel their growth with the support of a team of experts with extensive public and private sector experience. 

“Canada wins when cutting-edge companies keep operations, profits, and jobs here at home. And when they scale up around the world, they signal that Canada is open for business,” said Minister Mary Ng. “With the Global Hypergrowth Project, we're doubling down on Canada's most promising firms, to help them scale up, from here.” 

Clarius has an ambitious mission to improve patient care globally and reduce healthcare costs by enabling clinicians to instantly look into a patient’s body to confidently diagnose disease and enhance procedural safety. The company was the first to develop a high-definition pocket-size wireless ultrasound scanner that works with an app on Apple and Android smart devices. Since Clarius began selling its ultrasound scanners in 2016, more than 20,000 clinicians have used them performing more than 3.8 million scans. Clarius currently employs over 150 people at its headquarters, an innovation center and manufacturing facility in Vancouver, British Columbia. 

“We share the government of Canada’s goal to build a vibrant, local medical technology community and we’re extremely honoured to be one of a select few innovative companies in Canada chosen to participate in the Global Hypergrowth Project,” said Clarius CEO Ohad Arazi. “Having our government’s support for funding, international expansion, access to government procurement projects, and more will help rapidly accelerate our growth. Our team is energized to be recognized as one of Canada’s 15 most promising companies!” 

Minimum criteria for participation in the GHP include: annual revenues of $30 million; 40% gross margin; 30% revenue compound annual growth over the last three years; and headquarters in Canada with at least 60% employees based in the country. Clarius underwent a rigorous selection process to demonstrate its ability to execute on growth ambitions and prove its potential to seize opportunities for global leadership and to create and maintain highly-skilled jobs in Canada. Clarius was selected by a volunteer panel of notable Canadian business leaders appointed by Innovation Canada. 

Clarius is the only ultrasound company to offer 10 AI-powered models of handheld ultrasound scanners designed for a broad range of medical specialists including orthopedic surgeons, aesthetic clinicians, emergency physicians, and veterinarians. 

For more information: www.clarius.com


Related Content

News | Artificial Intelligence

September 25, 2023 — Viz.ai, a leader in AI-powered disease detection and intelligent care coordination, today announced ...

Time September 25, 2023
arrow
Feature | Magnetic Resonance Imaging (MRI) | Robert L. Bard, MD, and Lennard M. Gettz, EdD

Since the advent of the magnetic resonance imaging (MRI) exam on human patients in the late 1970s, this innovation ...

Time September 25, 2023
arrow
News | Cardiac Imaging

September 21, 2023 — Declines in cardiovascular procedure volumes observed early in the COVID-19 pandemic greatly ...

Time September 21, 2023
arrow
News | X-Ray

September 21, 2023 — Scientists in Moscow have successfully engineered a prototype detector for X-ray and PET/CT ...

Time September 21, 2023
arrow
Feature | Radiation Oncology

The radiation oncology community lost a leader this past summer, with the passing of Jay Loeffler, MD, FACR, FASTRO. He ...

Time September 21, 2023
arrow
News | Enterprise Imaging

September 20, 2023 — aycan, a recognized leader in medical imaging, announced today a new solution for reviewing DICOM ...

Time September 20, 2023
arrow
Feature | Radiation Dose Management | By Melinda Taschetta-Millane

Early-stage detection is key to the prevention of life-threatening diseases; however, limited access to data hinders the ...

Time September 20, 2023
arrow
Feature | Ultrasound Imaging | By Mustafa Hassan, PhD

Handheld ultrasound has not yet reached mainstream adoption, but the market is still forecast to reach over $500 million ...

Time September 20, 2023
arrow
News | Radiology Business

September 20, 2023 — GE HealthCare released its inaugural Sustainability Report, which describes the steps the company ...

Time September 20, 2023
arrow
News | Artificial Intelligence

September 20, 2023 — Medical imaging artificial intelligence (AI) company Annalise.ai has announced that the results ...

Time September 20, 2023
arrow
Subscribe Now